{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T00:27:27Z","timestamp":1793924847038,"version":"4.8.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.vaccine.2026.129265","type":"journal-article","created":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:26:12Z","timestamp":1792509972000},"page":"129265","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Quantifying the impact of pathogen interactions on vaccine effectiveness estimates in the test-negative design"],"prefix":"10.1016","volume":"94","author":[{"given":"Zibin","family":"Cai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linli","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuyi","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingxian","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2026.129265_bb0005","series-title":"Vaccines E-book","author":"Plotkin","year":"2012"},{"issue":"6","key":"10.1016\/j.vaccine.2026.129265_bb0010","first-page":"2052","article-title":"The case test-negative design for studies of the effectiveness of influenza vaccine in inpatient settings","volume":"45","author":"Foppa","year":"2016","journal-title":"Int J Epidemiol"},{"issue":"9","key":"10.1016\/j.vaccine.2026.129265_bb0015","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1093\/cid\/ciaa1453","article-title":"Incorporating real-time influenza detection into the test-negative design for estimating influenza vaccine effectiveness: the real-time test-negative design (rtTND)","volume":"72","author":"Feldstein","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"37","key":"10.1016\/j.vaccine.2026.129265_bb0020","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES2013.18.37.20585","article-title":"The test-negative design: validity, accuracy and precision of vaccine efficacy estimates compared to the gold standard of randomised placebo-controlled clinical trials","volume":"18","author":"De Serres","year":"2013","journal-title":"Euro Surveill"},{"issue":"12","key":"10.1016\/j.vaccine.2026.129265_bb0025","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1093\/cid\/cis307","article-title":"Increased risk of noninfluenza respiratory virus infections associated with receipt of inactivated influenza vaccine","volume":"54","author":"Cowling","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"15","key":"10.1016\/j.vaccine.2026.129265_bb0030","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1016\/j.vaccine.2018.02.105","article-title":"Assessment of temporally-related acute respiratory illness following influenza vaccination","volume":"36","author":"Rikin","year":"2018","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129265_bb0035","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.amepre.2022.02.008","article-title":"The association between previous influenza vaccination and COVID-19 infection risk and severity: a systematic review and meta-analysis","volume":"63","author":"Su","year":"2022","journal-title":"Am J Prev Med"},{"issue":"3","key":"10.1016\/j.vaccine.2026.129265_bb0040","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1093\/infdis\/jiab594","article-title":"Sequential delivery of live attenuated influenza vaccine and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the ferret model can reduce SARS-CoV-2 shedding and does not result in enhanced lung pathology","volume":"225","author":"Ryan","year":"2022","journal-title":"J Infect Dis"},{"issue":"1623","key":"10.1016\/j.vaccine.2026.129265_bb0045","first-page":"20120150","article-title":"Vacated niches, competitive release and the community ecology of pathogen eradication","volume":"368","author":"Lloyd-Smith","year":"2013","journal-title":"Philos Trans R Soc Lond Ser B Biol Sci"},{"issue":"52","key":"10.1016\/j.vaccine.2026.129265_bb0050","doi-asserted-by":"crossref","first-page":"27142","DOI":"10.1073\/pnas.1911083116","article-title":"Virus-virus interactions impact the population dynamics of influenza and the common cold","volume":"116","author":"Nickbakhsh","year":"2019","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"10.1016\/j.vaccine.2026.129265_bb0055","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3201\/eid2802.211727","article-title":"Viral interference between respiratory viruses","volume":"28","author":"Piret","year":"2022","journal-title":"Emerg Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2026.129265_bb0060","doi-asserted-by":"crossref","first-page":"e321","DOI":"10.1016\/j.ijid.2012.01.003","article-title":"Epidemiology, microbiology, and treatment considerations for bacterial pneumonia complicating influenza","volume":"16","author":"Metersky","year":"2012","journal-title":"Int J Infect Dis"},{"issue":"191","key":"10.1016\/j.vaccine.2026.129265_bb0065","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3005982","article-title":"Identifying the interaction between influenza and pneumococcal pneumonia using incidence data","volume":"5","author":"Shrestha","year":"2013","journal-title":"Sci Transl Med"},{"issue":"4","key":"10.1016\/j.vaccine.2026.129265_bb0070","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.ijantimicag.2019.08.012","article-title":"Ceftaroline fosamil as a potential treatment option for Staphylococcus aureus community-acquired pneumonia in adults","volume":"54","author":"Welte","year":"2019","journal-title":"Int J Antimicrob Agents"},{"issue":"8","key":"10.1016\/j.vaccine.2026.129265_bb0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008761","article-title":"The pneumococcal two-component system SirRH is linked to enhanced intracellular survival of Streptococcus pneumoniae in influenza-infected pulmonary cells","volume":"16","author":"Reinoso-Vizca\u00edno","year":"2020","journal-title":"PLoS Pathog"},{"issue":"4","key":"10.1016\/j.vaccine.2026.129265_bb0080","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1469-0691.2010.03167.x","article-title":"Rhinoviruses delayed the circulation of the pandemic influenza A (H1N1) 2009 virus in France","volume":"16","author":"Casalegno","year":"2010","journal-title":"Clin Microbiol Infect"},{"issue":"6","key":"10.1016\/j.vaccine.2026.129265_bb0085","doi-asserted-by":"crossref","first-page":"e254","DOI":"10.1016\/S2666-5247(20)30114-2","article-title":"Interference between rhinovirus and influenza a virus: a clinical data analysis and experimental infection study","volume":"1","author":"Wu","year":"2020","journal-title":"Lancet Microbe"},{"issue":"23","key":"10.1016\/j.vaccine.2026.129265_bb0090","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00881-18","article-title":"Attenuation of influenza A virus disease severity by viral coinfection in a mouse model","volume":"92","author":"Gonzalez","year":"2018","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2026.129265_bb0095","article-title":"Suppression of influenza virus infection by rhinovirus interference - at the population, individual and cellular levels","volume":"3","author":"Tao","year":"2022","journal-title":"Curr Res Microb Sci"},{"issue":"3","key":"10.1016\/j.vaccine.2026.129265_bb0100","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1093\/infdis\/jiy184","article-title":"Investigating viral interference between influenza a virus and human respiratory syncytial virus in a ferret model of infection","volume":"218","author":"Chan","year":"2018","journal-title":"J Infect Dis"},{"issue":"15","key":"10.1016\/j.vaccine.2026.129265_bb0105","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.00765-22","article-title":"The host response to influenza A virus interferes with SARS-CoV-2 replication during coinfection","volume":"96","author":"Oishi","year":"2022","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129265_bb0110","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1080\/22221751.2021.2021806","article-title":"Sequential infections with rhinovirus and influenza modulate the replicative capacity of SARS-CoV-2 in the upper respiratory tract","volume":"11","author":"Essaidi-Laziosi","year":"2022","journal-title":"Emerg Microbes Infect"},{"issue":"7","key":"10.1016\/j.vaccine.2026.129265_bb0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1012017","article-title":"Viral interference between severe acute respiratory syndrome coronavirus 2 and influenza a viruses","volume":"20","author":"Gilbert-Girard","year":"2024","journal-title":"PLoS Pathog"},{"issue":"4","key":"10.1016\/j.vaccine.2026.129265_bb0120","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1097\/EDE.0000000000000670","article-title":"Assessment of virus interference in a test-negative study of influenza vaccine effectiveness","volume":"28","author":"Feng","year":"2017","journal-title":"Epidemiology"},{"issue":"1966","key":"10.1016\/j.vaccine.2026.129265_bb0125","article-title":"The pitfalls of inferring virus-virus interactions from co-detection prevalence data: application to influenza and SARS-CoV-2","volume":"289","author":"Domenech de Cell\u00e8s","year":"2022","journal-title":"Proc Biol Sci"},{"issue":"19","key":"10.1016\/j.vaccine.2026.129265_bb0130","first-page":"185","article-title":"Vaccines against influenza: WHO position paper \u2013 May 2022","volume":"97","author":"World Health Organization","year":"2022","journal-title":"Wkly Epidemiol Rec"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129265_bb0135","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2024.2435156","article-title":"Influenza vaccine effectiveness against medically-attended influenza infection in 2023\/24 season in Hangzhou, China","volume":"21","author":"Lei","year":"2025","journal-title":"Hum Vaccin Immunother"},{"issue":"12","key":"10.1016\/j.vaccine.2026.129265_bb0140","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1093\/aje\/kwy163","article-title":"Measurement of vaccine direct effects under the test-negative design","volume":"187","author":"Lewnard","year":"2018","journal-title":"Am J Epidemiol"},{"issue":"52","key":"10.1016\/j.vaccine.2026.129265_bb0145","doi-asserted-by":"crossref","first-page":"7297","DOI":"10.1016\/j.vaccine.2017.10.107","article-title":"On the bias of estimates of influenza vaccine effectiveness from test-negative studies","volume":"35","author":"Ainslie","year":"2017","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2026.129265_bb0150","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/aje\/kww064","article-title":"Theoretical basis of the test-negative study design for assessment of influenza vaccine effectiveness","volume":"184","author":"Sullivan","year":"2016","journal-title":"Am J Epidemiol"},{"issue":"12","key":"10.1016\/j.vaccine.2026.129265_bb0155","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1017\/S0950268814000107","article-title":"Potential effect of virus interference on influenza vaccine effectiveness estimates in test-negative designs","volume":"142","author":"Suzuki","year":"2014","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2026.129265_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2024.126662","article-title":"Moderate effectiveness of influenza vaccine in outpatient settings: a test-negative study in Beijing, China, 2023\/24 season","volume":"46","author":"Zhang","year":"2025","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129265_bb0165","doi-asserted-by":"crossref","DOI":"10.1080\/22221751.2025.2490531","article-title":"Influenza vaccine effectiveness among primary and secondary school students in Shenzhen during the 2023\/24 influenza season","volume":"14","author":"Jiang","year":"2025","journal-title":"Emerg Microbes Infect"},{"issue":"8","key":"10.1016\/j.vaccine.2026.129265_bb0170","doi-asserted-by":"crossref","DOI":"10.1093\/jpids\/piaf069","article-title":"Effectiveness of cell culture-based influenza vaccine, 2023-2024","volume":"14","author":"Nguyen","year":"2025","journal-title":"J Pediatric Infect Dis Soc"},{"issue":"8","key":"10.1016\/j.vaccine.2026.129265_bb0175","doi-asserted-by":"crossref","first-page":"168","DOI":"10.15585\/mmwr.mm7308a3","article-title":"Interim estimates of 2023-24 seasonal influenza vaccine effectiveness - United States","volume":"73","author":"Frutos","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"10","key":"10.1016\/j.vaccine.2026.129265_bb0180","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofaf560","article-title":"Effectiveness of the 2023 southern hemisphere influenza vaccine against outpatient influenza-like illness: a multi-country test-negative design study","volume":"12","author":"Regan","year":"2025","journal-title":"Open Forum Infect Dis"},{"issue":"23","key":"10.1016\/j.vaccine.2026.129265_bb0185","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2025.30.23.2500011","article-title":"Influenza vaccine effectiveness in Europe and the birth cohort effect against influenza A(H1N1)pdm09: VEBIS primary care multicentre study, 2023\/24","volume":"30","author":"Kissling","year":"2025","journal-title":"Euro Surveill"},{"issue":"17","key":"10.1016\/j.vaccine.2026.129265_bb0190","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1016\/j.vaccine.2013.02.053","article-title":"The test-negative design for estimating influenza vaccine effectiveness","volume":"31","author":"Jackson","year":"2013","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129265_bb0195","doi-asserted-by":"crossref","DOI":"10.1038\/s41541-023-00716-9","article-title":"The need for a clinical case definition in test-negative design studies estimating vaccine effectiveness","volume":"8","author":"Sullivan","year":"2023","journal-title":"npj Vaccines"},{"issue":"30","key":"10.1016\/j.vaccine.2026.129265_bb0200","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.1016\/j.vaccine.2013.04.026","article-title":"The case test-negative design for studies of the effectiveness of influenza vaccine","volume":"31","author":"Foppa","year":"2013","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2026.129265_bb0205","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1093\/aje\/kwy240","article-title":"A dynamic model for evaluation of the bias of influenza vaccine effectiveness estimates from observational studies","volume":"188","author":"Ainslie","year":"2019","journal-title":"Am J Epidemiol"},{"issue":"4","key":"10.1016\/j.vaccine.2026.129265_bb0210","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1093\/aje\/kwz019","article-title":"Re: \"measurement of vaccine direct effects under the test-negative design\"","volume":"188","author":"Dean","year":"2019","journal-title":"Am J Epidemiol"},{"issue":"2","key":"10.1016\/j.vaccine.2026.129265_bb0215","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1093\/aje\/kwx251","article-title":"Estimating influenza vaccine effectiveness with the test-negative design using alternative control groups: a systematic review and meta-analysis","volume":"187","author":"Feng","year":"2018","journal-title":"Am J Epidemiol"},{"issue":"6","key":"10.1016\/j.vaccine.2026.129265_bb0220","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1093\/cid\/cit379","article-title":"Influenza vaccination is not associated with detection of noninfluenza respiratory viruses in seasonal studies of influenza vaccine effectiveness","volume":"57","author":"Sundaram","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2026.129265_bb0225","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1097\/EDE.0b013e31826b300e","article-title":"Virus interference and estimates of influenza vaccine effectiveness from test-negative studies","volume":"23","author":"Cowling","year":"2012","journal-title":"Epidemiology"},{"issue":"11","key":"10.1016\/j.vaccine.2026.129265_bb0230","doi-asserted-by":"crossref","first-page":"6118","DOI":"10.21037\/jtd.2018.10.33","article-title":"Clinical features of mycoplasma pneumoniae coinfection and need for its testing in influenza pneumonia patients","volume":"10","author":"Kim","year":"2018","journal-title":"J Thorac Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129265_bb0235","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s12890-022-02005-y","article-title":"Clinical significance of respiratory virus coinfection in children with Mycoplasma pneumoniae pneumonia","volume":"22","author":"Choo","year":"2022","journal-title":"BMC Pulm Med"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129265_bb0240","doi-asserted-by":"crossref","first-page":"10066","DOI":"10.1038\/s41467-024-53872-4","article-title":"Characterizing the interactions between influenza and respiratory syncytial viruses and their implications for epidemic control","volume":"15","author":"Kramer","year":"2024","journal-title":"Nat Commun"},{"issue":"6","key":"10.1016\/j.vaccine.2026.129265_bb0245","doi-asserted-by":"crossref","first-page":"469","DOI":"10.7883\/yoken.67.469","article-title":"Associations between co-detected respiratory viruses in children with acute respiratory infections","volume":"67","author":"Kaida","year":"2014","journal-title":"Jpn J Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2026.129265_bb0250","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/jmv.25333","article-title":"Epidemiology of human adenovirus infection in children hospitalized with lower respiratory tract infections in Hunan, China","volume":"91","author":"Xie","year":"2019","journal-title":"J Med Virol"},{"issue":"4","key":"10.1016\/j.vaccine.2026.129265_bb0255","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3947\/ic.2016.48.4.309","article-title":"Clinical impact of mixed respiratory viral infection in children with adenoviral infection","volume":"48","author":"Lee","year":"2016","journal-title":"Infect Chemother"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26010741?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26010741?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T23:53:54Z","timestamp":1793922834000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X26010741"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":51,"alternative-id":["S0264410X26010741"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.129265","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quantifying the impact of pathogen interactions on vaccine effectiveness estimates in the test-negative design","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.129265","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"129265"}}